RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,472 | +7.9% | 105,067 | +28.9% | 0.00% | – |
| Q2 2023 | $105,187 | -9.8% | 81,541 | -7.7% | 0.00% | – |
| Q1 2023 | $116,668 | +11.2% | 88,385 | +26.4% | 0.00% | – |
| Q4 2022 | $104,887 | +155.8% | 69,925 | +100.2% | 0.00% | – |
| Q3 2022 | $41,000 | +127.8% | 34,936 | +111.5% | 0.00% | – |
| Q2 2022 | $18,000 | -97.6% | 16,515 | -93.3% | 0.00% | -100.0% |
| Q1 2022 | $738,000 | -5.3% | 247,124 | -16.0% | 0.00% | 0.0% |
| Q4 2021 | $779,000 | – | 294,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |